Data / Form D filings / MYRIAD GENETICS INC
MYRIAD GENETICS INC: Form D filings
MYRIAD GENETICS INC, a biotechnology company in Salt Lake City, UT, filed 2 Form D notices with the SEC between 2017 and 2019. The latest, on February 12, 2019, reports $249,390 sold of a $249,390 offering to 1 investor.
Find out what MYRIAD GENETICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 320 WAKARA WAY, Salt Lake City, UT, 84108
- Phone
- (801) 584-3600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 899923
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2019 | Amendment | $249,390 | $249,390 | $0 | 1 | Feb 4, 2019 | sec.gov |
| Nov 14, 2017 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard S. Marsh | Executive Officer | |
| Lawrence C. Best | Director | |
| W. Lloyd Sanders | Executive Officer | |
| Dennis C. Langer | Director | |
| Mark C. Capone | Executive Officer, Director | |
| S. Louise Phanstiel | Director | |
| Alexander C. Ford | Executive Officer | |
| Bernard F. Tobin | Executive Officer | |
| Helner Bryan Dreismann | Director | |
| Walter C. Gilbert | Director | |
| Mark F. Verratti | Executive Officer | |
| Gary A. King | Executive Officer | |
| John T. Henderson | Director | |
| Richard Bryan Riggsbee | Executive Officer | |
| Ralph L. McDade | Executive Officer | |
| Jerry S. Lanchbury | Executive Officer |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 14 LLC offering · Nov 9, 2026
- Life Impact Partners 15 LLC offering · Nov 9, 2026
- Life Impact Partners 7 LLC offering · Nov 6, 2026
- Life Impact Partners 6 LLC offering · Nov 6, 2026
- Life Impact Partners 3 LLC offering · Nov 6, 2026
- Life Impact Partners 5 LLC offering · Nov 6, 2026
- Life Impact Partners 4 LLC offering · Nov 6, 2026
- Life Impact Partners 2 LLC offering · Nov 6, 2026
- Life Impact Partners 8 LLC offering · Nov 6, 2026
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Feb 11, 2019 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MYRIAD GENETICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.